Results 181 to 190 of about 84,228 (303)
PhDStem cell therapy represents a potential -cell replacement strategy in diabetes and a pancreatic cancer (PC) stem cell is an attractive therapeutic target in this dire disease. However, a normal stem cell remains unidentified and proposed malignant
Guppy, Naomi J
core
ABSTRACT Background Steatotic liver disease (SLD) is an unrecognized complication after pancreaticoduodenectomy (PD) and may affect nutrition and long‐term recovery. This meta‐analysis estimated the incidence of SLD after PD and identified its clinical and surgical risk factors.
Ronnakorn Kongsakon +4 more
wiley +1 more source
ABSTRACT Background/Purpose Prognostic significance of preoperative patient‐related factors, including oral health status, in pancreatic ductal adenocarcinoma (PDAC) remains unclear. We evaluated the association between preoperative factors—particularly oral health parameters—and long‐term survival after curative PDAC resection.
Kaoru Seo +8 more
wiley +1 more source
Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. [PDF]
Nagaraju GP +9 more
europepmc +1 more source
Myeloid sarcoma presenting as an isolated pancreatic mass in a 3‐year‐old child
Abstract Myeloid sarcoma (MS) is an extramedullary tumor of myeloid precursor cells, frequently associated with acute myeloid leukemia (AML), and rarely occurring in isolation. We present a child with obstructive jaundice secondary to a pancreatic head mass.
Jappmann Kaur Monga +7 more
wiley +1 more source
KRAS Inhibition in Pancreatic Ductal Adenocarcinoma. [PDF]
Pradeep R +5 more
europepmc +1 more source
ABSTRACT Background and Objectives To evaluate the prognostic significance of baseline and longitudinal changes in prognostic nutritional index (PNI) in localized pancreatic ductal adenocarcinoma (PDAC) and to assess the complementary prognostic value of PNI with tumor burden measured by circulating tumor DNA (ctDNA).
Alex Horowitz +9 more
wiley +1 more source
The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review. [PDF]
Pîntea AI +3 more
europepmc +1 more source
ABSTRACT Background There are no consensus guidelines for staging laparoscopy (SL) in pancreatic ductal adenocarcinoma (PDAC) and existing data largely reflect insured referral populations. Routine SL has not been studied in underserved patient populations who face disparities in cancer diagnosis and treatment.
David M. Holmes +3 more
wiley +1 more source
Alpha-Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC): A Case Report. [PDF]
Zhong K +7 more
europepmc +1 more source

